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Abstract 
Various defect-engineered Zr-trimesate MOF-808 compounds (DE-MOF-808) have been 
prepared by mixing the tricarboxylate ligands with dicarboxylate ligands; viz. 
isophthalate, pyridine-3,5-dicarboxylate, 5-hydroxy-isophthalate, or 5-amino-
isophthalate. The resulting mixed-ligand compounds, MOF-808-X (X = IP, Pydc, OH or 
NH2) were all found to be highly crystalline and isostructural to the unmodified MOF-
808. Pristine MOF-808 showed better catalytic performance than a UiO-66 reference 
compound for the Meerwein-Ponndorf-Verley (MPV) reduction of carbonyl compounds. 
This was attributed to a higher availability of coordinatively unsaturated Zr4+ sites (cus) 
in MOF-808 upon removal of formate ions. Meanwhile, cus in UiO-66 are only located 
at defect sites and are thus much less abundant. Further improvement of the catalytic 
activity of defect-engineered MOF-808-IP and MOF-808-Pydc was observed, which may 
be related with the occurrence of less crowded Zr4+ sites in DE-MOF-808. The wider pore 
structure of MOF-808 with respect to UiO-66 compounds translate into a sharp 
improvement of the activity for the MPV reduction of bulky substrates, as shown for 
estrone reduction to estradiol. Interestingly, MOF-808 produces a notable 
diastereoselectivity towards the elusive 17-α-hydroxy estradiol.   
 
Keywords: Metal Organic Frameworks; heterogeneous catalysis; MOF-808; Zr-MOFs, 
Diastereoselective Meerwein-Pondorf-Verley; estrone reduction. 
Introduction 
 Metal Organic Frameworks (MOFs) are crystalline hybrid materials formed by metal 
ions (or oxoclusters) connected to polytopic organic molecules through coordination 
bonds forming extended mono-, bi- or tridimensional networks defining a strictly regular 
system of pores and cavities of molecular dimensions.1 The huge variability of chemical 
compositions and pore architectures, the large surface areas and pore volumes attainable 
with these materials, and the possibility to introduce new functionalities in preformed 
MOFs through post-synthesis methods,2, 3 all make MOFs excellent candidates for a 
number of technological applications, including heterogeneous catalysis.4-7 In this sense, 
the Zr-containing terephthalate known as UiO-668 and its derivatives have attracted a 
great deal of attention in recent years.9-13 These compounds are formed by hexameric 
[Zr6O4(OH)4] octahedral oxoclusters connected by 12 terephthalate linkers into a face 
centered cubic packing. The high coordination number of the inorganic building units 
endows the material with a remarkable thermal, chemical and mechanical stability,14 
which is seldom found in many known MOF compounds. Together with this high 
stability, an attractive characteristic of UiO-66-type compounds is the possibility to 
prepare a battery of derivatives by introducing additional functional groups in the 
terephathalate linkers15-17 and to prepare expanded versions of UiO-66 by replacing 
terephthalate by longer linear dicarboxylate linkers (viz., UiO-67, UiO-68 and related 
compounds18). However, the coordination sphere of Zr4+ ions in UiO-66 is completely 
blocked by the carboxylate linkers, thus lacking coordination vacancies available for 
substrate binding. Therefore, UiO-66 materials rely on the formation of linker defects 
(either intrinsic or intentional) to display the reactivity typical of solid acid catalysts.9, 19 
In this way, it is well know that a direct correlation exist between the number of missing 
linker defects and the catalytic activity of UiO-66.9 A second limitation of UiO-66 is that 
it features a relatively narrow pore system, accessible through windows of about 6 Å,8 
which largely delimits the substrates that can reach the active sites located at the internal 
surface, and thus, the reactivity scope of this material. 
 Motivated by the excellent catalytic properties displayed by UiO-66-type materials, 
and in an attempt to overcome the two limitations mentioned above (viz., lack of 
coordination vacancies and narrow pore system), we have addressed our efforts to other 
Zr-containing compounds. Among several possible candidates, we have found that Zr 
trimesate known as MOF-80820 can be an interesting alternative with a high potential for 
catalytic applications. This compound has similar Zr6-oxoaggregates than those present 
in UiO-66, forming a tridimensional network with cavities of 18.4 Å and apertures of 14 
Å (see Fig. 1). In the MOF-808 structure, each cluster is connected by 6 trimesate linkers, 
while the other coordination positions of Zr ions are saturated by bridging formate 
molecules. These formate molecules can be removed by simple solvent washing or mild 
thermal treatment, thus leaving two coordination vacancies on each metal site.  
 
 
Fig 1. Structure of MOF-808, showing the Zr6 oxoaggregates and evidencing the large 
adamantane-like cavities. C, black; O, red; Zr, blue polyhedra. H atoms are omitted for 
clarity. Yellow and orange balls indicate the space in the framework. Reproduced with 
permission from Ref. 20. Copyright 2014 American Chemical Society. 
 
 Besides MOF-808, other wide pore compounds containing similar Zr6 oxoaggregates 
with open metal sites might be considered as well,18 such as NU-1000,21 PCN-222,22 
PCN-700,23 DUT-51,24 or the PIZOFs.25 However, a clear drawback of these compounds 
is that they usually require the use of non-commercial and/or expensive organic ligands, 
which introduce additional synthesis steps and rise up the final price, thus hampering the 
large scale synthesis of these MOFs. This is in sharp contrast with readily available and 
cheap trimesic acid used in the synthesis of MOF-808. 
 In order to increase further the availability of the Zr sites in MOF-808, we have 
prepared defect-engineered MOF-808 materials (DE-MOF) by a mixed-ligand approach 
(see Scheme 1). Thus, we have combined the tritopic trimesic acid ligands (1) with a 
small amount (ca. 10%) of a ditopic ligand, such as isophtalic acid (2), pyridine-3,5-
dicarboxylic acid (3), or 5-hydroxy- (4) and 5-amino-isophthalic acid (5) to prepare a 
series of mixed-ligand MOFs. A similar strategy has been shown to increase the number 
of open metal sites in related Cu26 and Ru27, 28 trimesate compounds, which translated into 
a considerable improvement of the catalytic properties of the DE-MOF with respect to 
the pristine compound. 
 
 
Scheme 1. Trimesate (1) is combined with various ditopic ligands (2-5) to prepare defect-
engineered MOF-808, DE-MOFs. 
 
 Herein, we have investigated the catalytic properties of both, pristine and DE-MOF-
808 compounds, and the results have been compared with those obtained over UiO-66 as 
a reference compound. As a test reaction, we have considered the Meerwein-Ponndorf-
Verley reduction of carbonyl compounds using an alcohol as reducing agent. Indeed, de 
Vos and co-workers have recently shown that MOF-808 can efficiently catalyse this 
reaction.29 The benefits of MOF-808 having a wider pore system and a higher 
concentration of coordinatively unsaturated Zr4+ sites (cus), as compared with UiO-66, 
are evidenced by studying the reduction of ketones of different size. 
 
Experimental section 
Synthesis of pristine and DE-MOFs 
MOF-808: Pristine zirconium MOF-808 material was prepared with slightly 
modifications from an earlier reported procedure by Furukawa et. al.20 Briefly, a solution 
was prepared containing 242,5 mg of ZrOCl2*8H20 (0,75 mmol), 105 mg of trimesic acid 
(0,5 mmol) and 22,5 mL of a DMF/HCO2H 1:1 (v/v) mixture. The solution was 
transferred into a Teflon lined autoclave and heated inside an oven at 130 °C for 48 h. 
After cooling down to room temperature, the material was recovered by centrifugation 
 
and washed for 3 days with DMF (changing the solvent 2 times per day) and for another 
3 days with EtOH (changing the solvent 2 times per day). After removing the solvent by 
centrifugation, the solid was dried in air. X-ray diffraction (PhillipsX’Pert, Cu Kα 
radiation) was used to confirm the expected structure type and high crystallinity of the 
material. 
DE-MOF-808: DE-MOF-808 materials were prepared by replacing 10 mol% of trimesic 
acid by equimolar amounts of defective linker: a) isophthalic acid (8,3 mg, 0,05 mmol) 
for MOF-808-IP, b) 3,5-pyridinedicarboxylic acid (8,4 mg, 0,05 mmol) for MOF-808-
Pydc, c) 5-hydroxyisophthalic acid (9,1 mg, 0,05 mmol) for MOF-808-OH and d) 5-
aminoisophthalic acid (9,1 mg, 0,05 mmol) for MOF-808-NH2. The remaining synthesis 
steps were kept the same as for the pristine MOF-808 material. 
UiO-66: The reference zirconium terephthalate UiO-66 material was prepared according 
to the reported procedure.16 Briefly, 750 mg of ZrCl4 and 740 mg of terephthalic acid 
were dissolved in 90 mL of DMF (Zr:ligand:DMF molar ratio of 1:1:220) and the solution 
was kept in a closed round bottom flask at 80ºC in an oil heating bath for 12 h without 
stirring, followed by another 24 h at 100ºC. The resulting material was recovered by 
filtration and washed thoroughly with fresh DMF. Then the solid was washed three times 
by soaking in dichloromethane for 3 h. Finally, the solid was recovered by filtration and 
dried under vacuum. The amount of missing linker defects in this UiO-66 sample was 
estimated to be ca. 7% from the corresponding TGA curve, following the method 
proposed by Valenzano et. al.30 
DUT-67: ZrCl4 (1.38 g, 6 mmol) was dissolved in 150 mL of N,N-dimethylformamide/N-
methyl-2-pyrrolidone mixture (DMF/NMP, 1:1) by ultrasonication for 10 minutes. 
Afterwards, 2,5-thiophenedicarboxylic acid (0.66 g, 4 mmol) was added and the mixture 
was sonicated again for 5 minutes. Then formic acid (26.8 mL, 120 eq) was added and 
the resulting mixture was divided in to 3 parts and distributed between three Schott flasks 
(500 mL each) and placed into an oven for 72 h at 85 °C. The white precipitate was 
filtered off and washed several times with DMF.  
 
Results and discussion 
Synthesis and characterization of pristine and DE-MOF-808 
 Pristine MOF-808 was prepared following the procedure reported by Furukawa et al.20 
Slightly modified synthesis were used to prepare the mixed-ligand, defect engineered 
MOFs, by replacing 10% of the trimesate ligands by the defect-inducing ditopic ligands, 
as described in detail in the Experimental section. These compounds will be hereafter 
referred to as MOF-808-X; where X = IP (isophthalate), Pydc (pyridine-3,5-
dicarboxylate), OH (5-hydroxy-isophthalate), or NH2 (5-amino-isophthalate). 
 According to the powder X-ray diffraction patterns shown in Fig. 2, all the materials 
were found to be isostructural and highly crystalline. All the diffraction peaks can be 
assigned to the expected structure for MOF-808 (space group Fd-3m, spn topology). 1H 
NMR of the digested solids (see Fig.S1 in the ESI) confirmed the incorporation of the 
ditopic ligands. Characteristic peaks of the ligands were used to determine the amount of 
dicarboxylate ligands incorporated in each case, as summarized in Table S1 (ESI). 
Incorporation of the defective ligands was found to be very low in all cases (ca. ~3-7%). 
It was not possible to increase these values even when the amount of defective ligand 
introduced in the starting reaction mixture was increased from 10% to 20%. As a 
consequence, no significant differences were observed in the FTIR or TGA curves of 
pristine and DE-MOF compounds. Meanwhile, introduction of ditopic ligands in MOF-
808 produced only minor changes on the textural properties of MOF-808, as summarized 
in Table S2 (ESI). For instance, SBET and pore volume varied from 1345 m2g-1 and 0.60 
cm3g-1 for pristine MOF-808, to 1592 m2g-1 and 0.74 cm3g-1 for the most porous sample, 
MOF-808-Pydc.   
 
 
Fig. 2. X-ray diffraction patterns (Cu Kα radiation) of (from bottom to top): MOF-808, 
MOF-808-IP, MOF-808-Pydc, MOF-808-OH and MOF-808-NH2. 
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Catalytic properties of pristine and DE-MOF-808 
Meerwein-Ponndorf-Verley reduction of cyclohexanone. The catalytic activity of 
pristine and DE-MOFs for the MPV reduction of carbonyl compounds was first evaluated 
using cyclohexanone as a model compound and isopropanol as both reducing agent and 
solvent. The results were then compared with a reference UiO-66 material containing ca. 
7% of linker defects measured under the same reaction conditions. Fig. 3 and Table 1 
summarize the results obtained. 
 
 
Fig. 3. Conversion of cyclohexanone over: MOF-808 (curve 1), MOF-808-IP (curve 2), 
MOF-808-Pydc (curve 3), and a reference UiO-66 containing ca. 7% missing linker 
defects (curve 4). 
 
 As it can be seen in Fig. 3, conversion of cyclohexanone is almost complete after 2 h 
using the pristine MOF-808 catalyst. The reaction was found to be fully selective, being 
cyclohexanol the only product detected in all cases. MOF-808 was found to be much 
more active than the reference UiO-66 compound. Thus for instance, cyclohexanone 
conversion after 1 h was 69% and 12% over MOF-808 and UiO-66, respectively 
(compare entries 1 and 3 in Table 1). In our opinion, this difference in activity shall not 
be attributed to eventual diffusion problems in the case of UiO-66, since cyclohexanone 
is small enough to enter the pores of UiO-66 (see Fig. S2 in ESI). Indeed, full 
cyclohexanone conversion is slowly attained after ca. 24 h over UiO-66 (Fig. S3 in ESI). 
Moreover, SEM revealed that both UiO-66 and MOF-808 have similar particle size (see 
Fig. S4 in ESI), so that no significant differences are expected in the amount of sites 





































exposed at the external surface of the crystallites. Rather, the difference in reactivity 
between MOF-808 and UiO-66 is most likely due to the higher concentration of Zr 
coordinatively unsaturated metal sites in the former material, created upon removal of the 
formate anions during catalyst activation. As we have mentioned above, UiO-66 lacks 
such open metal sites, and the only coordination positions available are those associated 
with missing linkers. Note that, according to the model suggested in ref. 9 for missing 
linker defects, an UiO-66 sample with 7% of missing linkers defects contains only 14% 
of the total Zr ions exposed and available for the reaction (each missing linker molecule 
creates two open metal sites, one in each of two neighbour oxoaggregates). In contrast, 
all Zr ions are accessible in MOF-808 after removal of the formate ligands.  
 To complete our study, and in order to lend further support to our conclusion that the 
observed differences in catalytic activity are related directly with the relative amount of 
available active sites, we have included a third Zr-containing MOF in the present study, 
DUT-67.31 In this compound, the Zr6 clusters are connected to 8 carboxylate ligands, thus 
lying between MOF-808 (6-connected) and UiO-66 (12-connected). As expected, the rate 
of cyclohexanone reduction is also intermediate between that observed for MOF-808 and 
UiO-66 (see Fig. S3 in ESI). 
Table 1. MPV reduction of cylohexanone over various Zr-MOFs.a 
 
 
Entry Catalyst Time (h) Conv (mol%)b 
1 UiO-66 1 12 
2  24 >99 
3 MOF-808 1 69 
4  2 97 
5 MOF-808-IP 1 91 
6  2 >99 
7 MOF-808-Pydc 1 93 
8  2 >99 
a Reaction conditions: 10 mg cyclohexanone (0.1 mmol), iPrOH (0.5 mL, ca. 6.5 eq) and 
Zr-MOF (5 mg, ca. 14 mol% Zr), 80ºC. b Conversion, determined by GC. Selectivity to 
cyclohexanol was >99% in all cases. 
 Interestingly, the use of DE-MOFs, MOF-808-IP and MOF-808-Pydc, containing 
defect-inducing linkers, brings about a marked increase of the catalytic activity compared 
with the pristine MOF-808 (see Fig. 3). Thus, the yield of cyclohexanol obtained after 1 
h increased from 69% (MOF-808, entry 3) to 91% and 93% (MOF-808-IP and MOF-808-
Pydc, entries 5 and 7, respectively). FTIR spectroscopy of adsorbed CO at 77 K (see Fig 
S5 in ESI) revealed that both, the concentration and relative acid strength of the Zr4+ open 
metal sites are virtually identical in pristine MOF-808 and MOF-808-Pydc compounds. 
Therefore, we attribute the observed increment of the reactivity of DE-MOFs with respect 
to the pristine material to the creation of additional coordination vacancies on the already 
exposed Zr sites due to the replacement of tritopic trimesate ligands by the ditopic ligands, 
thus leaving less sterically crowded Zr active sites (see Fig. S6 in ESI). In this sense, it is 
important to stress that the generally accepted mechanism for the MPV reduction of 
ketones over Lewis acid catalysts assumes the simultaneous adsorption of the alcohol and 
the ketone on the active site and the direct hydrogen transfer from the alcohol to the 
ketone, involving a six-membered cyclic transition state, as shown in Scheme 2.32 
Therefore, it seems reasonable to hypothesize that less shielded Zr acid sites will form 
such a transition state more easily. Further computational studies are currently underway 
to evaluate this hypothesis in more detail. 
 
Scheme 2. Proposed transition state for the MPV reduction of cyclohexanone with 
isopropanol over Zr-containing MOF-808 compounds. 
 
 In the case of MOF-808-OH and MOF-808-NH2, no significant improvement was 
observed with respect to pristine MOF-808 (see Fig. S7 in ESI). This probably indicates 
that the presence of –OH and –NH2 groups in position 5 of the ligands introduces further 
steric hindrance around the Zr sites, similar to what happens in pristine MOF-808, thereby 
precluding any improvement of the catalytic activity with respect to the parent material.  
 Finally, it is important to point out that all the materials were found to be stable under 
the reactions conditions used, and no significant differences were observed in the 
corresponding XRDs of the materials after reaction (see Fig. S8 in ESI). Consequently, 
no significant decrease of the catalytic activity was observed upon reuse of the material 
for at least 4 consecutive cycles. 
 
Meerwein-Ponndorf-Verley reduction of estrone (E1). As we have mentioned in the 
Introduction, MOF-808 has a wider pore system with respect to UiO-66, with pore entries 
of about 14 Å and 6 Å, respectively. From the catalytic point of view, this is a clear 
advantage when dealing with the conversion of bulky substrates (with a size comprised 
between 6 and 14 Å), which will only react at the external surface of UiO-66 but will 
freely diffuse inside the pores of MOF-808, thus reaching all the active sites. 
 In order to evaluate the benefits of a wide-pore catalyst such as MOF-808 as compared 
with UiO-66, we have studied the MPV reduction of a bulky ketone: estrone (E1, 
approximate dimensions: 11.2 Å x 6.2 Å x 4.2 Å, as extracted from the optimized 
structure using MOPAC2016,33 see Fig. S9 in ESI). A summary of the results obtained 
with various Zr-MOF catalysts is shown in Table 2. 
 
Table 2. MPV reduction of estrone over various Zr-MOFs.a 
 
 
Entry Catalyst Time (h) Conv (mol%)b d.r.c 
1 UiO-66 48 2 n.d. 
2 MOF-808 4 24  
3  24 87 40:60 
4 MOF-808-Pydc 4 61  
5  24 91 38:62 
a Reaction conditions: 20 mg estrone (0.08 mmol), iPrOH (1 mL, ca. 16 eq) and Zr-MOF 
(5 mg, ca. 18 mol% Zr), 80ºC. b Conversion. Determined by GC. Estradiols were the only 
product detected. c α−E2:β-E2 diastereomeric ratio, calculated from the 1H NMR spectra 
of the reaction filtrates (for the exact procedure used, see Fig.S10 in ESI). 
 
 Under the experimental conditions used, UiO-66 was found to be almost inactive for 
the reduction of estrone (only 2% conversion after 48 h). This is most likely due to a size-
exclusion effect, which prevents the large estrone molecule to cross the ~6 Å triangular 
pores to reach the active sites located (mostly) at the internal surface of UiO-66. On the 
contrary, almost full estrone conversion was attained over the wide pore MOF-808 
materials after 24 h of reaction, with full selectivity to the expected estradiol (E2). As it 
was the case of cyclohexanone reduction, the introduction of defective-inducing 
pyridinedicarboxylate ligands was found to be beneficial for the catalytic activity. Thus, 
the conversion obtained after 4 h of reaction was 24% and 61%, respectively for MOF-
808 and MOF-808-Pydc. However, the catalytic performance of MOF-808-IP was very 
similar to that of the pristine MOF-808: maximum yield of 78% after 24 h. This lower 
activity with respect to MOF-808-Pydc might be related to a faster deactivation associated 
to product adsorption, although more experiments would be necessary to reach a more 
satisfactory explanation. 
 In general, the synthesis of 17α-hydroxy steroids (such as α-E2) by reduction of the 
corresponding 17-oxo compound is challenging. Usually, the 17β isomer is obtained 
almost exclusively when NaBH4 or other reducing agents are employed, due to the steric 
hindrance imposed by the 18-methyl group on the approaching direction of the reducing 
agent. Additional reactions are then required to produce the inversion of the 17β-hydroxy 
steroids to the 17α compounds through Mitsunobu reactions,34 which involve multiple 
protection-deprotection steps. And even then, the yields and selectivities to the 17α-OH 
steroids are only moderate at best. For example, Han et al. reported on the synthesis of a 
related 17α-OH steroid (5α-androstane-3β,17α-diol) from the 17-oxo compound by a 4-
steps reaction involving reduction, tosylation, acetate substitution and hydrolysis, with a 
final yield of the 17α product as low as 4%.35 Ohta et al. reported later a modification of 
this procedure by adding three additional steps: epoxidation with peracetic acid, reduction 
with NaBH4 and hydrolysis with NaOH. The reported final yield of the 17α-OH 
compound was 54%.36 Göndös and Orr followed a different approach to 17α-OH steroid 
compounds by using a chiral Rh complex as stereoselective reducing agent, yielding the 
17α-hydroxy-estrone-3-methyl ether in 36%, together with the 17β-compound in 26% 
yield.37 
 Given the elusive character of the 17α-hydroxy steroid derivatives, it is evident that 
development of alternative preparative methods would be highly desirable. In this sense, 
it would be very convenient to use easily recoverable (and cheap) solid catalysts, along 
with the design of single step reaction processes and minimization of waste generation 
and use of additional reagents. 
 Therefore, given the well known high chemo-, regio- and stereoselectivity attainable 
with MPV reactions,32 we have evaluated the diastereomeric ratio between alpha- and 
beta-estradiol (α-E2 and β-E2) obtained using both MOF-808 and MOF-808-Pydc as 
catalysts. Interestingly, we found that both materials afforded a mixture of the two 
alcohols in a ca. 40:60 α:β ratio, which translates into an overall yield of ca. 35% of the 
α-E2 isomer after 24 h of reaction time. This finding is most probably related with the 
relative steric hindrance of the two transition states leading to α-E2 and β-E2 products 
inside the restricted space of the MOF cavities, similar to what was already pointed out 
for MPV reactions taking place inside the pores of zeolites.38, 39 Although the 
stereoselectity attained with MOF-808 compounds is still far from optimal, it is worth 
mentioning that 17α-hydroxy-estradiol was cleanly obtained directly from estrone with 
moderate yields in a single reaction step, using only isopropanol as the sole reagent and 
avoiding any additional protection/deprotection steps. Isolation of pure α and β isomers 
from the reaction filtrate can be readily achieved by TLC or column purification without 
any further workout.  
 
Conclusions 
 Herein we have reported on the synthesis of various defect-engineered MOF-808 
materials by mixing the tricarboxylate trimesate ligands of MOF-808 with dicarboxylate 
ligands; viz. isophthalate (IP), pyridine-3,5-dicarboxylate (Pydc), 5-hydroxy-isophthalate 
(OH), or 5-amino-isophthalate (NH2). The resulting mixed-ligand compounds, MOF-
808-X (X = IP, Pydc, OH or NH2) were all found to be highly crystalline and isostructural 
to the unmodified MOF-808. 
 The catalytic activity of pristine and mixed-ligand MOF-808 compounds have been 
evaluated for the Meerwein-Ponndorf-Verley (MPV) reduction of carbonyl compounds 
using isopropanol as reducing agent, and the results were compared with a reference UiO-
66 material containing ca. 7% of linker defects. When a small molecule such as 
cyclohexanone was used as substrate, MOF-808 was found to be more active than UiO-
66. The higher activity of MOF-808 with respect to UiO-66 was attributed to the fact that 
in MOF-808, all Zr4+ ions are accessible and can participate in the reaction (once the 
bridging formate ions are removed). Meanwhile, the only accessible acid sites in UiO-66 
are those associated with linker defects (which represent only 14% of the total Zr ions of 
the solid). Partial replacement of trimesate linkers in MOF-808 by ditopic ligands results 
in a further improvement of the catalytic performance with respect to the pristine MOF-
808. This is probably related to the creation of less hindered Zr open metal sites when 
dicarboxylate ligands are used, which facilitate the formation of the 6-membered cyclic 
transition state (see Scheme 2). The presence of wide pores in MOF-808 with respect to 
UiO-66 translates into a significant improvement of the catalytic activity for converting 
bulky substrates, as it is shown here for the reduction of estrone to estradiol. Interestingly, 
the process produces reasonable amounts of the elusive 17α-hydroxy estradiol in a single 
reaction step.  
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